Close Menu

NEW YORK (360Dx) – Danaher's Leica Biosystems said today that the US Food and Drug Administration has cleared its Aperio AT2 DX System for clinical diagnosis in the US.

The Aperio AT2 DX System is a high-throughput automated scanning and viewing platform. Vista, California-based Leica said that it will be launched with clinical image management software for an integrated digital pathology workflow solution.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.